E-LIB Suche - Ergebnisse für: Kuntz, KM

1

EE127 Evidence and Uncertainty in an Iterative Decision-Mak..:

Kunst, N ; Burger, EA ; Coupé, VM..
Value in Health. 25 (2022) 12 - p. S77-S78 , 2022

Link: https://doi.org/10.1016/..

2

Force Of Infection Of Helicobacter Pylori In Mexico: Eviden..:

Alarid-Escudero, F ; Enns, E ; Maclehose, R...
Value in Health. 20 (2017) 9 - p. A856 , 2017

Link: https://doi.org/10.1016/..

3

Calibration of Piecewise Markov Models Using a Change-Point..:

Alarid-Escudero, F ; Enns, E ; Peralta-Torres, YE..
Value in Health. 18 (2015) 7 - p. A814 , 2015

Link: https://doi.org/10.1016/..

4

MC7 THE PHARMACOGENOMICS BIAS IN DECISION MODELS:

Siebert, U ; Goldie, SJ ; Weinstein, MC.
Value in Health. 8 (2005) 6 - p. A17 , 2005

Link: https://doi.org/10.1016/..

5

PRPI 9: BONE MINERAL DENSITY LOSS AFFECTS ESTIMATES OF THE ..:

Paltiel, AD ; Fuhlbrigge, AL ; Kitch, BT...
Value in Health. 6 (2003) 3 - p. 369 , 2003

Link: https://doi.org/10.1016/..

6

PCV34 COST-EFFECTIVENESS OF FRACTIONAL FLOW RESERVE TESTING..:

Siebert, U ; Greenberg, D ; Kuntz, KM.
Value in Health. 6 (2003) 6 - p. 655-656 , 2003

Link: https://doi.org/10.1016/..

7

PNP34: PATIENT PREFERENCE-BASED TREATMENT RECOMMENDATIONS F..:

Araki, SS ; Kuntz, KM ; Llewellyn-Thomas, H...
Value in Health. 6 (2003) 3 - p. 284 , 2003

Link: https://doi.org/10.1016/..

8

UT4 PATIENT-DERIVED UTILITY ESTMATES OF CHRONIC HEPATITIS C..:

Greiner, W ; Ravens-Sieberer, U ; Schulz, KH...
Value in Health. 5 (2002) 6 - p. 460-461 , 2002

Link: https://doi.org/10.1016/..

9

Informing medication discontinuation decisions among older ..:

Schwehr, NA ; Kuntz, KM ; Enns, EA...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047543/. , 2020

Link: http://www.ncbi.nlm.nih...

10

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Scr..:

Naber, Steffie ; Kundu, S ; Kuntz, KM...
Naber , S , Kundu , S , Kuntz , KM , Dotson , WD , Williams , MS , Zauber , AG , Calonge , N , Zallen , DT , Ganiats , TG , Webber , EM , Goddard , KAB , Henrikson , NB , Ballegooijen , M , Janssens , A & Lansdorp - Vogelaar , I 2020 , ' Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential ' , JNCI Cancer Spectrum , vol. 4 , no. 1 , UNSP pkz086 . https://doi.org/10.1093/jncics/pkz086. , 2020

Link: https://pure.eur.nl/en/p..

11

Age-Related Decreases in Relapses among Adults with Relapsi..:

Schwehr, NA ; Kuntz, KM ; Butler, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986982/. , 2019

Link: http://www.ncbi.nlm.nih...

12

Cost-effectiveness of a multitarget stool DNA test for colo..:

Naber, Steffie ; Knudsen, AB ; Zauber, AG...
Naber , S , Knudsen , AB , Zauber , AG , Rutter , CM , Fischer , S E , Pabiniak , CJ , Soto , B , Kuntz , KM & Lansdorp - Vogelaar , I 2019 , ' Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries ' , PLoS One (print) , vol. 14 , no. 9 , e0220234 . https://doi.org/10.1371/journal.pone.0220234. , 2019

Link: https://pure.eur.nl/en/p..

13

Development of a blood test to screen for colorectal cancer..:

Haug, U ; Knudsen, AB ; Kuntz, KM
http://dx.doi.org/10.3205/11gmds008. , 2011

Link: https://doi.org/10.3205/..

14

A Cost-Effectiveness Analysis of Folic Acid Fortification P..:

Bentley, Tanya G ; Weinstein, Milton C ; Willett, Walter C.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856722. , 2008

Link: http://www.ncbi.nlm.nih...

15

Evaluating the Pharmacogenomics Bias in Decision-Analytic M..:

Siebert, U ; Goldie, SJ ; Weinstein, MC.
Jukema JW, Bruschke AV, van Boven AJ, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, van Rappard FM, Lie KI. (1995). Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91(10): 2528-40.. , 2005

Link: http://www.egms.de/en/me..